The updated CPG includes 21 recommendations (14 strong and seven moderate) and eight options (four limited and four consensus). Options are formulated with low-quality evidence, no evidence, or ...

Recovery is more than ending a bad habit. It’s about healing your body, rebuilding your mind, and learning healthier patterns. Residential therapy gives you structure and care, but long-term healing ...

The global Electrophysiology Market, valued at US$11.41 billion in 2024, stood at US$12.55 billion in 2025 and is projected to advance at a resilient CAGR of 11.6% from 2025 to 2030, culminating in a ...

The ADAPT study will evaluate the safety and effectiveness of the company's Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System Myra Vision, a Shifamed portfolio company, announced today ...

It seems we can't find what you're looking for.

The contract was awarded based on the recommendation of the Karma Fixation System by hospital experts who serve on one of Vizient's client-led councils, and it signifies to Vizient provider clients ...

Norwalt, a specialist in custom-built automation and line integration machinery for complex manufacturing applications, announces its strategic partnership with ei 3, a global leader in industrial ...

This funding will support the development of Avian H5 Influenza detection capabilities on the Metrix® platform, expanding upon its recent U.S. Food and Drug Administration (FDA) emergency use ...

When it comes to bed bugs, no one’s immune. Whether you’re in a studio apartment or a five-star resort, an infestation can strike without warning—and dealing with it can quickly become a costly ...

As part of the transaction, HealthMark management and existing investor Ridgemont Equity Partners will both roll meaningful ownership stakes, welcoming TA as the new lead investor. Financial terms of ...

Founder Greg Sullivan will transition into the role of Chief Technology Officer to focus on advancing MMS's technology platform, next-generation product development, and clinical evidence initiatives.

The MR-139 3001 Phase 3 trial consisted of a randomized, placebo-controlled, double-masked prospective study, with a total of 477 patients who were randomized to receive either MR-139 or placebo, self ...